Drug intelligence / Profile preview

Tavipec

Development stage
Unknown
Lead developer
Montavit
Modality
Small Molecules
Administration
Oral
01

Overview

Tavipec is a herbal medicinal product developed by Pharmazeutische Fabrik Montavit for the treatment of respiratory tract disorders. Its active ingredient is 150 mg of spike lavender oil (*Lavandula latifolia* essential oil), obtained via steam distillation of the flowering tops. Formulated as enteric-coated soft capsules for oral administration, Tavipec acts as a secretolytic and expectorant, facilitating the liquefaction of viscous mucus and enhancing mucociliary clearance. It also exhibits bronchospasmolytic, antiseptic, and anti-inflammatory properties. The drug is primarily indicated for the treatment of acute and chronic rhinosinusitis, acute and chronic bronchitis, and coughs associated with the common cold. The enteric coating ensures that the essential oil is released in the small intestine, avoiding gastric irritation and ensuring systemic absorption to reach the respiratory tract.

Brand names
TavipecTavipec capsules
Other names
spike lavender oilLavandula latifolia essential oilaetheroleum spicae

Beyond the preview

Go deeper on Tavipec.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tavipec.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call